Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer (DOPMET)
This study is currently recruiting participants.
Study NCT00647140   Information provided by Assistance Publique - Hôpitaux de Paris
First Received: March 26, 2008   Last Updated: January 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thyroid Neoplasm
Thyroid Carcinoma
Medullary Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Medullary
Neoplasms
Thyroid Neoplasms
More general conditions related to this trial
Adenocarcinoma
Carcinoma, Neuroendocrine
Endocrine Gland Neoplasms
Endocrine System Diseases
Head and Neck Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Ductal, Lobular, and Medullary
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Thyroid Diseases
Interventions listed in this trial
18F-L-DOPA PET
Additional drug interventions recognized in this trial
Dihydroxyphenylalanine
Levodopa
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services